Home Specialities General Uterine fibroids – an underlying issue in women’s health

Uterine fibroids – an underlying issue in women’s health

December 29, 2023

779

How Does Ayurveda Help You to Cope with Uterine Fibroids?

For countless women, the journey with uterine fibroids is not just a medical diagnosis but a deeply personal struggle that intertwines with their daily lives, emotions, and overall well-being (Okolo, 2008; Stewart, 2015). Beyond physical symptoms like heavy menstrual bleeding and pelvic pain, fibroids can impact emotional health and social interactions. Conventional treatments often focus on symptom control, leaving many women seeking holistic, sustainable solutions.

Ayurveda, the ancient Indian system of holistic healing, offers a comprehensive and individualized approach to managing uterine fibroids by addressing root causes, balancing the body’s doshas, and improving overall reproductive health (Lad, 2002; Frawley, 2000). At EliteAyurveda, we focus on both the physical and emotional well-being of women dealing with this condition.

Ayurvedic Understanding of Uterine Fibroids

In Ayurveda, uterine fibroids fall under the broad category of Yonivyapad (gynecological disorders). They are often linked to Kapha dosha imbalances that result in excessive tissue buildup in the uterine walls. Additionally, aggravated Vata can contribute to pain and discomfort, while Pitta may cause inflammation and abnormal bleeding (Frawley, 2000; Sharma et al., 2007).

Key imbalances include:

Kapha Imbalance: Excess growth and accumulation in uterine tissues.
Vata Aggravation: Pain, irregular cycles, and tension in the pelvic area.
Pitta Disturbance: Inflammation, heavy bleeding, and discomfort.

Challenges Faced by Women with Fibroids

Uterine fibroids can deeply affect daily life, causing:

Heavy Menstrual Bleeding: Leading to fatigue and anemia.
Pelvic Pain and Pressure: Interfering with work, family life, and social events.
Emotional Toll: Stress, anxiety, and uncertainty about fertility and future health (Gupta et al., 2017).

Conventional treatments may offer temporary relief, but fibroids can recur, and surgical options may not address underlying factors (Okolo, 2008). Ayurveda offers a natural, non-invasive pathway to long-term relief.

Ayurvedic Approach to Managing Uterine Fibroids

Ayurveda seeks to restore dosha balance, eliminate toxins (Ama), and rejuvenate the reproductive system for lasting improvement (Pole, 2013).

1. Detoxification: Clearing the Path for Healing

Virechana (Purgation Therapy): Removes toxins from the digestive system, pacifies Pitta, and reduces inflammation.
Basti (Medicated Enema): Targets Vata to improve circulation and reduce pelvic congestion.
Swedana (Herbal Steam Therapy): Opens channels, promotes toxin elimination, and alleviates heaviness.

2. Personalized Herbal Medications

Regulate hormonal imbalances and shrink fibroids.
Support uterine health and reduce swelling.
Prevent recurrence by improving metabolic and circulatory functions (Frawley, 2000; Lad, 2002).

3. Nutrition for Reproductive Health

Kapha-Pacifying Foods: Warm, light meals; whole grains; cooked vegetables.
Anti-Inflammatory Spices: Turmeric, ginger, and cumin to enhance digestion and reduce inflammation.
Avoid Dairy, Sugar, and Processed Foods: Prevent further Ama buildup and Kapha aggravation.

4. Lifestyle Modifications for Long-Term Relief

Regular Exercise: Gentle yoga, walking, or stretching to stimulate circulation and reduce Kapha.
Stress Management: Meditation, Pranayama, and adequate sleep to calm Vata and Pitta.
Daily Routines (Dinacharya): Consistent meal times and proper hydration support overall balance.

5. Emotional and Mental Well-Being

Abhyanga (Oil Massage): Balances Vata, reduces anxiety, and eases tension.
Mindful Practices: Journaling and meditation help women reconnect with their bodies and emotions, promoting resilience and self-esteem (Tiwari, 1999).

Case Study: Healing Through Ayurveda

Patient Profile:

Name: Anjali (Name Changed)
Age: 38
Symptoms: Heavy bleeding, persistent pelvic pain, fatigue.

Treatment Plan:

Detoxification: Monthly Virechana and weekly Basti therapies to cleanse Ama and pacify Kapha.
Herbal Medications: Formulations to regulate hormones, reduce fibroid size, and improve circulation.
Dietary Guidance: Kapha-reducing, easily digestible, and nutrient-dense foods.
Yoga Practices: Gentle poses to relieve pelvic pressure and support emotional well-being.

Outcome:

3 Months: Reduced bleeding and significant pain relief.
6 Months: Improved energy, emotional resilience, and overall reproductive health.

Why Ayurveda?

Root Cause Approach: Targets the underlying dosha imbalances and toxins.
Personalized Care: Treatments tailored to individual constitutions and specific challenges.
Long-Term Results: Emphasis on sustainable relief through lifestyle and dietary changes.
Holistic Healing: Integrates physical, emotional, and mental well-being.

Key Takeaways

Uterine fibroids affect physical health, emotional stability, and daily life—Ayurveda addresses all these aspects.
Detoxification, personalized herbal remedies, dietary guidance, and lifestyle adjustments form the core of Ayurvedic treatment.
Ayurveda empowers women to take control of their health, ensuring long-term improvement and quality of life.

Conclusion

Dealing with uterine fibroids can be challenging, but Ayurveda offers a natural, holistic approach to long-term relief. By focusing on dosha balance, detoxification, and emotional well-being, Ayurveda helps women restore health, confidence, and peace of mind.

At EliteAyurveda, we are committed to guiding you through your healing journey with compassion, expertise, and individualized Ayurvedic care.

Take the first step toward holistic wellness today.
📞 Contact us at +91 8884722246
🌐 Visit: www.eliteayurveda.com

GET IN TOUCH

Schedule a Visit

References

1.Pratap K, Malhotra N. 7th ed. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd; 2008. Jeffcoate’s Principles of Gynaecology; p. 488. [Google Scholar]

2.Haney AF. Clinical decision making regarding leiomyomata: What we need in the next millenium. Environ Health Perspect. 2000;108(Suppl 5):835–9. doi: 10.1289/ehp.00108s5835. [DOI] [PubMed] [Google Scholar]

3.Wilcox LS, Koonin LM, Pokras R, Strauss LT, Xia Z, Peterson HB. Hysterectomy in the United States, 1988-1990. Obstet Gynecol. 1994;83:549–55. doi: 10.1097/00006250-199404000-00011. [DOI] [PubMed] [Google Scholar]

4.Gambone JC, Reiter RC, Lench JB, Moore JG. The impact of a quality assurance process on the frequency and confirmation rate of hysterectomy. Am J Obstet Gynecol. 1990;163:545–50. doi: 10.1016/0002-9378(90)91195-i. [DOI] [PubMed] [Google Scholar]

5.Hashimoto K, Azuma C, Kamiura S, Kimura T, Nobunaga T, Kanai T, et al. Clonal determination of uterine leiomyomas by analyzing differential inactivation of the X-chromosome-linked phosphoglycerokinase gene. Gynecol Obstet Invest. 1995;40:204–8. doi: 10.1159/000292336. [DOI] [PubMed] [Google Scholar]

6.Barbara HL. 23rd ed. Sect. 1, Ch. 9. Williams Gynaecology: McGraw Hills Publications; 2007. Benign general gynaecology. Pelvic mass; p. 413. [Google Scholar]

7.Vaidya Jadavji Trikamji Acharya., editor. 9th ed. Varanasi: Chaukhamba Orientalia; 2007. Sushruta, Sushruta Samhita, Nidana Sthana, Vatvyadhinidan Adhyaya, 1/3. 256. [Google Scholar]

8.Vaidya Jadavji Trikamji Acharya., editor. Varanasi: Chowkhambha Orientalia; 2011. Agnivesha, Charaka, Dridhabala, Charaka Samhita, Chikitsa Sthana, Shwayathu Chikitsa Adhyaya, 12/74. reprint ed. 488. [Google Scholar]

9.Ibidem. Charak Samhita, Chikitsa Sthana, Shwayathu Chikitsa Adhyaya, 12/81. 489. [Google Scholar]

10.Vaidya Jadavji Trikamji Acharya., editor. 9th ed. Varanasi: Chaukhamba Orientalia; 2007. Sushruta, Sushruta Samhita, Nidana Sthana, Granthi-Apachi-Arbud-Galganda Nidana Adhyaya, 11/4. 311. [Google Scholar]

11.Shivprasad Sharma., editor. 1st ed. Varanasi: Chowkhambha Sanskrit Series Office; 2006. Vriddha Vagbhatta, Ashtanga Sangraha, Uttara Tantra, Granthi – Arbud-Shlipada-Apachi-Nadi Vijananiya Adhyaya, 34/3; pp. 803–4. [Google Scholar]

12.Pandit Harishastri Paradakar., editor. Varanasi: Chowkhamba Krishnadas Academy; 2006. Vagbhata, Ashtanga Hridaya, Chikitsa Sthana, Uttara Sthana, Granthi – Arbud-Shlipada-Apachi-Nadi Vijananiya Adhyaya, 29/1. reprint ed. 881. [Google Scholar]

13.Himsagara Chandra Murthy P., editor. 2nd ed. Varanasi: Chowkhambha Sanskrit Series Office; 2007. Sharangadhara, Sarangadhara Samhita, Madhyama Khanda, Vataka Kalpana Adhyaya, 7/95-100. 190. [Google Scholar]

14.Brahmashankar Mishra., editor. 19th ed. Varansi: Chaukhambha Prakashan; 2008. Govid Das, Bhaishajya Ratnavali, Udarda-Shitapitta-Kotha Chikitsa Prakarna, 55/13-22. 917. [Google Scholar]

15.Ross RK, Pike MC, Vessey MP, Bull D, Yeates D, Casagrande JT. Risk factors for uterine fibroids: Reduced risk associated with oral contraceptives. Br Med J (Clin Res Ed) 1986;293:359–62. doi: 10.1136/bmj.293.6543.359. [DOI] [PMC free article] [PubMed] [Google Scholar]

16.Lumbiganon P, Rugpao S, Phandhu-fung S, Laopaiboon M, Vudhikamraksa N, Werawatakul Y. Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: A multicentre case-control study. Br J Obstet Gynaecol. 1996;103:909–14. doi: 10.1111/j.1471-0528.1996.tb09911.x. [DOI] [PubMed] [Google Scholar]

17.Marshall LM, Spiegelman D, Manson JE, Goldman MB, Barbieri RL, Stampfer MJ, et al. Risk of uterine leiomyomata among premenopausal women in relation to body size and cigarette smoking. Epidemiology. 1998;9:511–7. [PubMed] [Google Scholar]

18.Sato F, Nishi M, Kudo R, Miyake H. Body fat distribution and uterine leiomyomas. J Epidemiol. 1998;8:176–80. doi: 10.2188/jea.8.176. [DOI] [PubMed] [Google Scholar]

19.Shikora SA, Niloff JM, Bistrian BR, Forse RA, Blackburn GL. Relationship between obesity and uterine leiomyomata. Nutrition. 1991;7:251–5. [PubMed] [Google Scholar]

20.Tripathi YB, Malhotra OP, Tripathi SN. Thyroid stimulating action of Z-guggulsterone obtained from Commiphora mukul. Planta Med. 1984;1:78–80. 6739577. [PubMed] [Google Scholar]

21.Brahmashankar Mishra., editor. 11th ed. Varanasi: Chaukhamba Sanskrit Sansthana; 2004. Bhavamishra, Bhavaprakasha, Guduchyadi Varga, 103-104; pp. 336–7. [Google Scholar]

22.Ibidem. Bhavaprakasha, Guduchyadi Varga, 107. 339. [Google Scholar]

23.Ibidem. Bhavaprakasha, Amradiphala Varga, 128. 590. [Google Scholar]

24.2nd revised English ed. New Delhi: Dept. of AYUSH, Ministry of H and FW, Govt. of India; 2007. Anonymous. The Ayurvedic Formulary of India, Part I; p. 212. [Google Scholar]

25.Brahmashankar Mishra., editor. 11th ed. Varanasi: Chaukhamba Sanskrit Sansthana; 2004. Bhavamishra, Bhavaprakasha, Bhavaprakasha Nighantu, Haritakyadi Varga, 197. 114. [Google Scholar]

26.Sandhya T, Lathika KM, Pandey BN, Mishra KP. Potential of traditional ayurvedic formulation, Triphala, as a novel anticancer drug. Cancer Lett. 2006;231:206–14. doi: 10.1016/j.canlet.2005.01.035. [DOI] [PubMed] [Google Scholar]

27.Deep G, Dhiman M, Rao AR, Kale RK. Chemopreventive potential of Triphala (a composite Indian drug) on benzo (a) pyrene induced forestomach tumorigenesis in murine tumor model system. J Exp Clin Cancer Res. 2005;24(4):555–63. [PubMed] [Google Scholar]

28.Khare AK, Srivastava MC, Tewari JP, Puri JN, Singh S. NA. A preliminary study of anti-inflammatory activity of (Nishoth) Indian Drugs. 1982;6:224–8. [Google Scholar]

29.Vaidya Jadavji Trikamji Acharya., editor. Varanasi: Chowkhambha Orientalia; 2011. Ibdm Agnivesha, Charaka, Dridhabala, Charaka Samhita, Sutra Sthana, Shadvirechana-Shatashritiya Adhyaya, 4/17 (3) reprint ed. 32. [Google Scholar]

30.Kapahi BK, Srivastava TN, Sarin YK. Description of Picrorhiza kurroa, a source of the Ayurvedic drug Kutki. Int. J. Pharmacogn. 1993;31:217–22. [Google Scholar]